Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 19526730)

Published in Rev Neurosci on January 01, 2009

Authors

Volker Nimmrich1, Ulrich Ebert

Author Affiliations

1: Neuroscience Discovery, GPRD, Abbott, Ludwigshafen, Germany. volker.nimmrich@abbott.com

Articles citing this

Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) (2012) 1.61

The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis. J Neuroinflammation (2011) 1.26

Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Rep (2012) 1.25

Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One (2012) 1.25

NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal (2010) 1.22

Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med (2010) 1.13

The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res Ther (2010) 1.09

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus. Acta Neuropathol (2011) 1.09

Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des (2012) 1.06

Wnt-5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Mol Neurodegener (2010) 1.05

LRRK2 function on actin and microtubule dynamics in Parkinson disease. Commun Integr Biol (2010) 1.04

Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem (2010) 0.95

Phenserine efficacy in Alzheimer's disease. J Alzheimers Dis (2010) 0.92

Calcium channel blockers and dementia. Br J Pharmacol (2013) 0.91

The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage. Cell Signal (2011) 0.89

β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation. Eur J Neurosci (2010) 0.89

Presynaptic active zones in invertebrates and vertebrates. EMBO Rep (2015) 0.88

Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease. Front Physiol (2013) 0.88

Neuron specific toxicity of oligomeric amyloid-β: role for JUN-kinase and oxidative stress. J Alzheimers Dis (2010) 0.85

Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease. Front Aging Neurosci (2014) 0.84

Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease. J Alzheimers Dis (2014) 0.83

Alzheimer's disease and tauopathy studies in flies and worms. Neurobiol Dis (2010) 0.82

Multiple effects of β-amyloid on single excitatory synaptic connections in the PFC. Front Cell Neurosci (2013) 0.80

Ablation of Ca(V)2.1 voltage-gated Ca²⁺ channels in mouse forebrain generates multiple cognitive impairments. PLoS One (2013) 0.80

Dantrolene, a treatment for Alzheimer disease? Alzheimer Dis Assoc Disord (2015) 0.79

Intra-axonal protein synthesis in development and beyond. Int J Dev Neurosci (2016) 0.79

Characterization of age-related changes in synaptic transmission onto F344 rat basal forebrain cholinergic neurons using a reduced synaptic preparation. J Neurophysiol (2013) 0.79

Scorpion Venom Heat-Resistant Peptide Protects Transgenic Caenorhabditis elegans from β-Amyloid Toxicity. Front Pharmacol (2016) 0.77

Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging (2016) 0.77

Early behavioral changes and quantitative analysis of neuropathological features in murine prion disease: stereological analysis in the albino Swiss mice model. Prion (2011) 0.77

Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease. Mol Neurobiol (2016) 0.77

Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy. J Mol Psychiatry (2016) 0.76

Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine. Evid Based Complement Alternat Med (2014) 0.75

Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons. Front Cell Neurosci (2017) 0.75

Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein. Aging Cell (2016) 0.75

Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanism. Pharmacol Res Perspect (2016) 0.75

The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo. Antioxid Redox Signal (2015) 0.75

Stabilization of dynamic microtubules by mDia1 drives Tau-dependent Aβ1-42 synaptotoxicity. J Cell Biol (2017) 0.75

Articles by these authors

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06

Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry (2009) 2.31

Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci (2008) 1.54

Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease. J Neurosci (2011) 1.36

Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. J Neurosci (2010) 1.20

Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol Aging (2010) 0.96

Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels. Neurobiol Dis (2005) 0.96

The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats. Eur J Neurosci (2004) 0.91

Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice. J Pharmacol Exp Ther (2010) 0.89

Excessive weight gain in rats over extended kindling of the basolateral amygdala. Neuroreport (2003) 0.80

Age-related changes in parvalbumin-positive interneurons in the striatum, but not in the sensorimotor cortex in dystonic brains of the dt(sz) mutant hamster. Brain Res (2007) 0.79

Amygdala-kindling does not induce a persistent loss of GABA neurons in the substantia nigra pars reticulata of rats. Brain Res (2004) 0.78

An ELISA-based method for the quantification of incorporated BrdU as a measure of cell proliferation in vivo. J Neurosci Methods (2006) 0.78